In Drosophila, broad complex, tramtrack, bric à brac (BTB)/ poxvirus and zinc finger (POZ) transcription factors are essential regulators of development. We searched the Drosophila genome for BTB/POZ-ZF domains and discovered an unknown Drosophila gene, dPLZF, which encodes an orthologue of human PLZF. We then characterized the biological function of the dPLZF via genetic interaction analysis. Ectopic expression of dPLZF in the wing induced extra vein formation during wing development in Drosophila. Genetic interactions between dPLZF and Ras or extracellular signal-regulated kinase (ERK) significantly enhanced the formation of vein cells. On the other hand, loss-of-function mutations in dPLZF resulted in a dramatic suppression of the extra and ectopic vein formation induced by elevated Ras/ERK signaling. Moreover, dPLZF activity upregulated the expression of rhomboid (rho) and spitz, which perform crucial functions in vein cell formation in the developing wing. These results indicate that dPLZF is a transcription factor controlled by the Ras/ERK signaling pathway, which is a prominent regulator of vein cell formation during wing development in Drosophila.
INTRODUCTION
The broad complex (BR-C), tramtrack (ttk), and bric à brac (bab) (BTB) domain, also known as the poxvirus and zinc finger (POZ) domain, has been identified as a conserved motif in transcription regulators that have crucial roles in Drosophila development (Albagli et al., 1995) . Ttk, a transcriptional repressor, is expressed in a complementary pattern to that of fushitarazu (ftz) throughout early embryogenesis (Harrison and Travers, 1990) . BR-C functions as a crucial regulator of gene activity at the onset of metamorphosis (DiBello et al., 1991; Karim and Rubin, 1998) . Bab is required for pattern formation along the proximal-digital axis of the leg and antenna (Godt et al., 1993) . All these factors contain this motif and are involved in Drosophila development.
The BTB/POZ domain is absolutely conserved from Drosophila to mammals and has been identified in more than 200 proteins in the human genome (Bardwell and Treisman, 1994) . In fact, the human promyelocytic leukemia zinc finger gene (PLZF) encodes a 673-amino acid transcription factor with a conserved BTB/POZ protein-protein interaction domain as well as a DNA-binding motif constructed from nine C 2 H 2 Krüppel-like type zinc fingers (ZFs). PLZF has been linked both directly and indirectly to tumorigenic and developmental processes, including pattern formation, metamorphosis, eye development, and limb development (Blair, 2007; Kelly and Daniel, 2006) . Specifically, a transgenic Drosophila strain that ectopically expresses the human hepatocytic ∆BTB-PLZF, a 45-kDa isoform of PLZF that lacks the BTB domain, showed phenotypic changes in eye and wing development via enhanced extracellular signalregulated kinase (ERK) signaling (Ko et al., 2006) . EOR-1, the C. elegans orthologue of human PLZF, also has been identified as a positive regulator of both the Ras and Wnt signaling pathways (Howard and Sundaram, 2002; Rocheleau et al., 2002) . The endogenous biological functions of PLZF, however, have yet to be elucidated.
In Drosophila, Ras/ERK signaling has been implicated in the regulation of a variety of processes, including cell proliferation (Karim and Rubin, 1998), differentiation (Fortini et al., 1992) , patterning (Schnorr and Berg, 1996) , apoptosis (Bergmann et al., 1998; Kurada and White, 1998) , cell migration (Lee et al., 1996) , cellular growth, and wing development (Blair, 2007; O'Keefe et al., 2007) . Ras activation results in the sequential activation of the highly conserved mitogen-activated protein kinase (MAPK) cascade, which includes Raf, MAP kinase kinase (MEK), and ERK. Among Ras regulators in Drosophila, rho activates epidermal growth factor receptor (Egfr) ligands and induces Ras activation via the transmembrane Egfr (Roch et al., 2002) . The expression of rho in the primordial vein is the initial step in the process of vein cell fate determination. Therefore, Ras/ERK activation in a specific row of cells determines the fate of the cells as future wing veins. Consistent with this observation, loss-of-function mutations of the Ras/ERK pathway components result in loss of veins, whereas gain-offunction alleles and/or overexpression of these components induce ectopic vein development (Brunner et al., 1994; Kim et al., 2006; Prober and Edgar, 2000; Sturtevant and Bier, 1995) . Additionally, phosphorylated cytoplasmic ERK promotes vein differentiation in the developing wing vein and margin cells during the larval and early pupal stage (Marenda et al., 2006) . Thus, Ras/ERK is critical for the control of vein differentiation and proliferation in Drosophila.
In this study, we isolated Drosophila PLZF (dPLZF), a novel gene that contains the BTB/POZ-ZF domain, and investigated the role of dPLZF during development in vivo. In order to assess the effects of ectopic expression and knockdown of this gene, we generated a transgenic fly that overexpresses fulllength dPLZF and two loss-of-function mutants of dPLZF. The ectopic expression of dPLZF in the wing phenocopied the overexpression of Ras/ERK pathway components. We also evaluated the epistatic interaction between dPLZF and components of the Ras/ERK pathway. Ras/ERK activity was enhanced by overexpression of dPLZF and was reduced in dPLZF loss-of-function mutants. Furthermore, we demonstrated a crucial function of dPLZF in larval development and survival. This study provides the first demonstration that dPLZF is an essential gene for wing vein formation and may function as a transcriptional regulator of the Ras/ERK pathway during wing development in Drosophila.
MATERIALS AND METHODS

Drosophila strains
The fly strains EP(2) 6792 (dPLZF), EP(2) 5575 (Ken & Barbie), EP(3) 6384 (Cp190), EP(X) 15725, EP(X) 32611, and EP(3) 6765 with an inserted EP (enhancer-promoter) element were obtained from GenExel. The vg-Ras
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, UAS-Draf, UAS-ERK (rolled), UAS-ERK S (rl sem ), P[Δ2-3]/Cyo, MS1096-Gal4, engrailed-Gal4 (en-Gal4), and vestigial-Gal4 (vg-Gal4) lines and a variety of Gal4 and balancer lines were acquired from the Bloomington Drosophila Stock Center. The RNAi CG6792 (dPLZF) lines were acquired from the Vienna Drosophila RNAi Center. All Drosophila stocks were maintained and cultured with standard medium at 25°C unless noted otherwise.
Generation of transgenic and null flies
To induce ectopic dPLZF expression (based on cDNA clone SD03430), we employed the UAS/GAL4 system. The dPLZF cDNAs were acquired from the Drosophila Genomics Resource Center. Transgenic flies were generated via injection of pUASTdPLZF and a helper plasmid into embryos. Injections were conducted prior to pole cell formation in stage 5 using an IM-300 microinjector (Narishige) and an Axiovert 25 micromanipulator (Carl Zeiss). To generate dPLZF loss-of-function mutants, we employed an EP line from the GenExel fly library. This line harbored an EP-element insertion closest to the center of the gene. The P-element from dPLZF was excised by crossing the flies with flies harboring Δ2-3 transposase. More than 200 excision lines were established and analyzed by PCR using primers flanking dPLZF.
Analysis of phenotypes and measurement of survival rate
The wings of adult flies were dissected from euthanized flies and mounted in 50% Canadian Balsam (Sigma) in methylsalicylate (Sigma). Adult wing phenotypes were observed via light microscopy (Leica CTR 6000). The number of extra veins per wing was counted for each genotype, and more than 200 wings for each genotype were employed for quantification. In order to assess the survival rate of dPLZF mutants from the embryo to adult stages, we calculated the percentage of embryos that survived to adulthood. Experiments were conducted in triplicate with 200 embryos per experiment. The average survival rate of three experiments is presented.
RT-PCR, realtime PCR and genomic PCR analysis Expression of dPLZF was analyzed via RT-PCR in dPLZFpositive or dPLZF-null flies. Total RNA was prepared with Trizol (Gibco/BRL) in accordance with the manufacturer's instructions. Messenger RNA was also isolated in accordance with the manufacturer's instructions (QIAGEN, Oligotex ® mRNA). Quantitative realtime PCR was performed with a Rotor Gene 6000 (Cobett Research) and a SYBR Green reaction (Qiagene) according to the manufacturer's instructions.The dPLZF cDNA was amplified using the following primer set: 5′-GGACTTCT TCTACGAGGATTTGGTGTCC-3′ and 5′-TTCTGTACCTGATA GCACTTGAAGTCGC-3′. Deletion sites within dPLZF were determined via genomic PCR analyses. The dPLZF mutants were detected with the following primer set: 5′-ACCCATGA CGGTGTTTGATATTCTGTAAAG-3′ and 5′-AGGCAACGCAT TTGTTTATTTCTGAATAG-3′.
Immunohistochemistry
In order to detect the increase of rhomboid (rho) in wing imaginal disc, third-instar larval wing discs were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 1 h at room temperature and then incubated first with Rho antibody (1:200; Developmental Studies Hybridoma Bank) and subsequently with Alexa Fluor 488 goat anti-mouse immunoglobulin G secondary antibody (1:200; Invitrogen). The samples were examined under a fluorescence microscope.
RESULTS
Drosophila PLZF encodes a BTB/POZ domain with ZF motifs To assess the roles of unknown genes containing BTB/POZ-ZF, we isolated the BTB/POZ-ZF-containing Drosophila genes CG6792 (dPLZF), Ken & Barbie, Cp190, CG15725, CG32611, and CG6765 in an EP line collection from GenExel and specifically overexpressed these genes in the eye and wing using the Gal4 system. Among the tested BTB/POZ-ZF genes, dPLZF induced phenotypic changes in wing development when overexpressed by the en-Gal4 and MS1096-Gal4 drivers. The dPLZF gene encodes a 469-amino acid protein that contains an N-terminal BTB/POZ domain and seven C-terminal C 2 H 2 ZF motifs (Fig. 1B) . The Drosophila PLZF (dPLZF), human PLZF, and C. elegans EOR-1 all harbor an N-terminal BTB/POZ domain ( Supplementary Fig. S1a ) and similarly spaced C 2 H 2 Krüppel-type ZF motifs ( Supplementary Fig. S1b ). Human PLZF and dPLZF are 32% identical and 44% similar over those regions. Previously, we found that the wings of a transgenic fly that expressed the human PLZF under the control of MS1096-Gal4 exhibited additional ectopic veins (Ko et al., 2006) . The wing phenotype of the dPLZF fly is similar to that of the human PLZF transgenic fly. These similarities indicate that dPLZF functions similarly to human PLZF. Therefore, dPLZF is an orthologue of human PLZF.
Mammalian PLZF expression has been reported in a variety
